Xylem is trading 8.28% down at $99.28 after lowering its 2026 outlook. - Third-quarter revenue was $2.2 billion, below the $2.28 billion estimate; adjusted EPS was $1.44 versus $1.45 expected. - Xylem now forecasts 2026 revenue of about $8.95 billion and adjusted EPS of $5.40–$5.45, down from $5.55–$5.70. - Management cited project timing and cautious customer spending; the company also announced plans to divest two businesses.